4
Changes in Ownership
Guardant Health, Inc. Filed Acc 0001702824-25-000008
Chief Financial Officer sold 80,362 shares at an average $103.14 ($8,288,742)
- Chief Financial Officer acquired 56,287 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bell Michael Brian · Chief Financial Officer
Table I: Non-derivative
14 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-05 | Exercise or conversion : show line 1 in the form | +29,382 | $32.86 | $965,493 | 81,509 | D |
| 2025-12-05 | Exercise or conversion : show line 2 in the form | +26,905 | $28.37 | $763,295 | 108,414 | D |
| 2025-12-05 | Sale : show line 3 in the form | −8,033 | $101.42 | $814,736 | 100,381 | D |
| 2025-12-05 | Sale : show line 4 in the form | −22,891 | $102.11 | $2,337,302 | 77,490 | D |
| 2025-12-05 | Sale : show line 5 in the form | −7,567 | $103.26 | $781,394 | 69,923 | D |
| 2025-12-05 | Sale : show line 6 in the form | −11,978 | $103.96 | $1,245,252 | 57,945 | D |
| 2025-12-05 | Sale : show line 7 in the form | −250 | $105.82 | $26,454 | 57,695 | D |
| 2025-12-05 | Sale : show line 8 in the form | −5,568 | $106.68 | $594,018 | 52,127 | D |
| Open-market sales · 80,362 sh · avg $103.14 · $8,288,742 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-05 | Exercise or conversion : show line 15 in the form Stock Option (Right to Buy) | −29,382 | 7,137 | D |
| 2025-12-05 | Exercise or conversion : show line 16 in the form Stock Option (Right to Buy) | −26,905 | 10,421 | D |
Loading xslF345X05/wk-form4_1765247822.xml…